Monday, July 1, 2013
Despite one segment that
finished the second quarter in the red, all market cap groups are still up for
the year. In 2Q13, the sector was led by large caps, which closed up 4%,
marking four straight quarters in the black.
Pharmaceuticals Inc. led the large caps. The company's 46% jump during
the quarter was driven by positive data from a Phase II trial of VX-661 to
treat cystic fibrosis (CF).